Edmonton, AB (CTI) – January 22, 2007 - Biomira Inc. (TSX: BRA; Nasdaq: BIOM) announced today that Eric E. Baker has retired from its board of directors effective January 19, 2007.

Baker had been a member of the board since 1985 and served as Chairman until September 2006.

Baker is President of Miralta Capital II Inc., a venture capital fund. Miralta Capital is an early backer of Biomira.

"It has been a pleasure to work with Eric. He has been a valuable resource to Biomira for more than 20 years and his services have been an asset to the Company. On behalf of Biomira's Board of Directors and the Company's management team, I wish Eric well in his future endeavors," commented Dr.Christopher S. Henney, Chairman of Biomira's board of directors.

Edmonton, Alberta based Biomira is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Biomira's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients.